Julius Wehrle

Oncogenic JAK2 ^V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

Alessandro Prestipino, Alica Joana Emhardt, Konrad Aumann et al. · Science Translational Medicine · 2018 · 224 citations

Medicine, Immunology, Oncology +17

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

Sushree Sangita Sahoo, Victor B. Pastor, Charnise Goodings et al. · Nature Medicine · 2021 · 168 citations · Full text

Life Sciences, Genetics, Hematology +17

Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas

Jurik Mutter, Stefan Alig, Mohammad Shahrokh Esfahani et al. · Journal of Clinical Oncology · 2022 · 126 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center Experience

Rouven Hoefflin, Anna-Lena Geißler, Ralph Fritsch et al. · JCO Precision Oncology · 2018 · 108 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer

Silvia Waldeck, Jan Mitschke, Sebastian Wiesemann et al. · Molecular Oncology · 2021 · 103 citations · Full text

Medicine, Molecular Medicine, Oncology +17